News

With fewer symptoms and less severe presentation, persistent depressive disorder (PDD) differs from clinical depression. If ...
That's why today, ketamine is increasingly being used to treat a variety of illnesses, including depression, anxiety, post-traumatic stress disorder (PTSD) and chronic pain. Practitioners employ the ...
Feeling constantly drained despite adequate rest? Discover five signs your persistent fatigue might indicate health issues ...
A retired San Francisco schoolteacher sued the US for $410,490 in tax refunds, alleging his persistent depressive disorder impaired his capacity to manage his financial affairs. Dennis Yabuki told the ...
A new study reveals that chronic stress activates immune cells that travel to the brain, amplify inflammation, and heighten fear responses.
If you've ever lived with pain that just won't quit, you're not alone. According to a Centers for Disease Control and Prevention report, chronic pain affected 51.6 million Americans in ...
Learn more about the uptick in psilocybin use, particularly in younger and older adults in the U.S.
Use of psilocybin has increased among all age groups since some states decriminalized the hallucinogen in 2019.
Mass General Brigham researchers found that immune cells influence brain communication in response to stress, driving fear ...
A new study raises mental health concerns about popular weight loss drugs like Ozempic and Mounjaro. These GLP-1 agonists, while effective for appetite control, may disrupt dopamine pathways linked to ...
Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...